A Potential Paradigm Shift in Cancer Therapy: Mitigating the Disease Without Killing Cancer Cells

In a tumor, even without treatment, a substantial number of cancer cells spontaneously die each day. This is due to the high rate of cell proliferation and the unstable nature of cancer cells, which often have defects in their DNA repair mechanisms and can be more prone to apoptosis (programmed cell death) or necrosis (cell death due to injury or disease). Scientists discovered that when cancer cells die, either spontaneously or from treatment such as chemotherapy, cell-free chromatin particles are released into the tumor microenvironment, where they are readily internalized by surviving cancer cells and inflict DNA damage, inflammation, immune suppression, increased toxicity from chemotherapy, and ultimately, more cancer.

Our DNA is stored on our chromosomes as densely packed units called chromatin which contains DNA and proteins called histones. This configuration prevents the long strands of DNA from becoming tangled and plays an important role in stabilizing the DNA during cell division, preventing DNA damage, and maintaining normal gene expression. Cell-free chromatin particles are composed of tiny fragments of DNA and histones without other cellular components. These particles are released from cancer cells undergoing apoptosis—the mechanism a cell undertakes for self-destruction, activated when the cell senses significant self-damage.

Scientists also found that cell-free chromatin particles are released into the bloodstream from the billions of normal cells that die each day as we age. These particles readily enter healthy cells and integrate into their DNA. This leads to DNA damage, mitochondrial dysfunction, activation of apoptotic and inflammatory pathways, and impairment of mitochondrial function. This process triggers a vicious cycle and ongoing chain reaction that perpetuates the aging process and increases the risk of cancer.

Some scientists believe that the lifelong assault on healthy cells by internalized cell-free chromatin particles may not only be the chief underlying cause of the aging process and cancer but also may act as a global instigator of other age-associated disorders, including cardiovascular disease, diabetes, sepsis, and Alzheimer’s disease. Fortunately, scientists may have found a way to safely neutralize cell-free chromatin particles.

Scientists discovered that very minute and specific oral doses of resveratrol and copper (click here) generate oxygen radicals in the stomach. These radicals are readily absorbed into the circulation and permeate the extracellular spaces, and deactivate cell-free chromatin particles. In an animal model, this was found to downregulate several biological hallmarks of aging and neurodegeneration. In a human model using patients with advanced oral cancer, it was found that deactivating cell-free chromatin particles downregulated the hallmarks of cancer, as well as five immune checkpoint (suppressor) proteins. This data suggests that prolonged treatment with resveratrol and copper may have the potential to induce healing without having to directly kill cancer cells.

In conclusion, this exciting area of research offers potential strategies for combating cancer and perhaps even aging itself. As we deepen our understanding of the role of cell-free chromatin particles and explore ways to neutralize them, we may find ourselves on the brink of significant advancements in human health and longevity.

Comments: It is important to note that higher doses of resveratrol and copper were far less effective than lower doses. Also, the combination of resveratrol and copper was found to target 21 out of 23 biomarkers representing 10 hallmarks of cancer. The two exceptions were VEGFA (angiogenesis) and GLUT1 (cellular energetics). Apigenin has been found to inhibit VEGFA and GLUT1. Adding a bioavailable form of this compound might allow one to target all 23 biomarkers and improve treatment outcomes even further.

References:

Agarwal A, Khandelwal A, Pal K, Khare NK, Jadhav V, Gurjar M, Punatar S, Gokarn A, Bonda A, Nayak L, Kannan S, Gota V, Khattry N, Mittra I. A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001). PLoS One. 2022 Feb 4;17(2):e0262212.

Fu J, Zeng W, Chen M, Huang L, Li S, Li Z, Pan Q, Lv S, Yang X, Wang Y, Yi M, Zhang J, Lei X. Apigenin suppresses tumor angiogenesis and growth via inhibiting HIF-1α expression in non-small cell lung carcinoma. Chem Biol Interact. 2022 Jul 1;361:109966.

Kirolikar S, Prasannan P, Raghuram GV, Pancholi N, Saha T, Tidke P, Chaudhari P, Shaikh A, Rane B, Pandey R, Wani H, Khare NK, Siddiqui S, D’souza J, Prasad R, Shinde S, Parab S, Nair NK, Pal K, Mittra I. Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death Dis. 2018 Nov 15;9(12):1142.

Mittra I, Pal K, Pancholi N, Shaikh A, Rane B, Tidke P, Kirolikar S, Khare NK, Agrawal K, Nagare H, Nair NK. Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin. Ann Oncol. 2017 Sep 1;28(9):2119-2127.

Mittra I, Pal K, Pancholi N, Tidke P, Siddiqui S, Rane B, D’souza J, Shaikh A, Parab S, Shinde S, Jadhav V, Shende S, Raghuram GV. Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice. PLoS One. 2020 Mar 4;15(3):e0229017.

Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, et al. Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Disc. 3: 17015.

Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, Pelling JC, Bentrem DJ. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas. 2008 Nov;37(4):426-31.

Pal K, Raghuram GV, Dsouza J, Shinde S, Jadhav V, Shaikh A, Rane B, Tandel H, Kondhalkar D, Chaudhary S, Mittra I. A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice. Sci Rep. 2022 Oct 14;12(1):17209.

Pilankar A, Singhavi H, Raghuram GV, Siddiqui S, Khare NK, Jadhav V, Tandel H, Pal K, Bhattacharjee A, Chaturvedi P, Mittra I. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004). Front Oncol. 2022 Sep 16;12:1000957.

Raghuram GV, Chaudhary S, Johari S, Mittra I. Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer. Genes (Basel). 2019 May 28;10(6):407.

Raghuram GV, Tripathy B, Avadhani BK, Shabrish S, Khare NK, Lopes R, Pal K, Mittra I. Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells. bioRxiv 2021.12.30.47452.

Shabrish S, Pal K, Khare N,  Satsangi D, Pilankar A,  Jadhav V, Shinde S, Raphael N,  Sriram G, Relestina Lopes, Raghuram G,  Tandel H,  Mittra I. Cell-free chromatin particles activate immune checkpoints in human T cells: Implications for cancer therapy. bioRxiv 2023.06.09.544311.